TheraRadar
← Back
Data updated: Jun 28, 2026

CENTAUR PHARMACEUTICALS PRIVATE LIMITED

Pharma
Pharmaceuticals

CENTAUR PHARMACEUTICALS PRIVATE LIMITED is a pharmaceutical company with 1 FDA-approved products.

-
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

CENTAUR PHARMACEUTICALS PRIVATE LIMITED's Key Drugs

CENTAUR PHARMACEUTICALS PRIVATE LIMITED's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

CENTAUR PHARMACEUTICALS PRIVATE LIMITED's Recent FDA Approvals

New NDA/BLA approvals for CENTAUR PHARMACEUTICALS PRIVATE LIMITED over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

CENTAUR PHARMACEUTICALS PRIVATE LIMITED's Therapeutic Areas

Disease areas where CENTAUR PHARMACEUTICALS PRIVATE LIMITED has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

CENTAUR PHARMACEUTICALS PRIVATE LIMITED Pipeline Snapshot

Active clinical trials for CENTAUR PHARMACEUTICALS PRIVATE LIMITED across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Active trial monitoring
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling